December 27, 2014 2:21 AM ET

Biotechnology

Company Overview of Neuro Therapeutics Inc.

Company Overview

Neuro Therapeutics Inc. (NTI) is a privately held biomedical company developing therapies to promote the functional repair of the damaged spinal cord and brain. The lead technology for NTI involves a patented and patent-pending process for the transient immunological suppression of myelin surrounding a CNS injury site. On June 16, 2003, Neuro Therapeutics, Inc filed for bankruptcy under the laws of Canada.

Rm. 2469

6270 University Boulevard

Vancouver, BC V6T 1Z4

Canada

Phone:

(604) 822-0103

Fax:

(604) 822-2924

Key Executives for Neuro Therapeutics Inc.

Co Founder
Co-Founder and Chief Scientific Officer
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
AquaBounty Canada, Inc. Americas
InterOmex Biopharmaceuticals Inc. Americas
AlgaeCan Biotech Ltd. Americas
Anandia Laboratories Inc. Americas
Leap Medical Inc. Americas

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Neuro Therapeutics Inc., please visit www.neurotherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.